The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Abstract
Patients with primary sclerosing cholangitis (PSC) have a significantly increased risk of developing cholangiocarcinoma (CCA). Risk factors for developing such a complication are not well defined. We conducted a multicenter, case-control study to determine the risk factors and possible predictors for CCA in patients with PSC. The demographic, clinical, and laboratory features of 26 PSC patients with CCA diagnosed over a 7-year period at eight academic centers were compared with 87 patients with PSC but no CCA (controls). There was no statistically significant difference in demographics, smoking, signs or symptoms or complications of PSC, indices of disease severity (Mayo Risk score or Child-Pugh score), frequency or duration or complications of inflammatory bowel disease (IBD), frequency of biliary surgery, or therapeutic endoscopy between the two groups. Alcohol consumption was significantly associated with CCA in patients with PSC (odds ratio: 2.95; 95% CI: 1.04-8.3). Serum carbohydrate antigen 19-9 (CA 19-9) was significantly higher in patients with CCA than those without (177 ± 89 and 61 ± 58 U/mL, respectively;P = .002). A serum CA 19-9 level > 100 U/mL had 75% sensitivity and 80% specificity in identifying PSC patients with CCA. In conclusion, alcohol consumption was a risk factor for having CCA in PSC patients. The indices of severity of liver disease were not associated with CCA in patients with PSC. Serum CA 19-9 appeared to have good ability to discriminate PSC patients with and without CCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis
ROSEN, C. B., NAGORNEY, D. M., WIESNER, R. H., COFFEY, R. J., & LARUSSO, N. F. (1991) · Annals of Surgery · doi:10.1097/00000658-199101000-00004 · Cited by 391
Goss, J. A., Shackleton, C. R., Farmer, D. G., Arnaout, W. S., Seu, P., Markowitz, J. S., Martin, P., Stribling, R. J., Goldstein, L. I., & Busuttil, R. W. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00004 · Cited by 328
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
Ramage, J. K., Donaghy, A., Farrant, J. M., Iorns, R., & Williams, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90462-x · Cited by 279
Primary Sclerosing Cholangitis: A Long-Term Follow-up Study
Aadland, E., Schrumpf, E., Fausa, O., Elgjo, K., Heilo, A., Aakhus, T., & Gjone, E. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528709011139 · Cited by 276
NICHOLS, J. C., GORES, G. J., LARUSSO, N. F., WIESNER, R. H., NAGORNEY, D. M., & RITTS, R. E. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60696-x · Cited by 214
Kim, W. R., Poterucha, J. J., Wiesner, R. H., LaRusso, N. F., Lindor, K. D., Petz, J., Therneau, T. M., Malinchoc, M., & Dickson, R. E. (1999) · Hepatology · doi:10.1002/hep.510290607 · Cited by 141
Kornfeld, D., Ekbom, A., & Ihre, T. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011222 · Cited by 132
Primary sclerosing cholangitis is associated with nonsmoking: A case- control study
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613055 · Cited by 129
Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation
Nashan, B., Schlitt, H. J., Tusch, G., Oldhafer, K. J., Ringe, B., Wagner, S., & Pichlmayr, R. (1996) · Hepatology · doi:10.1002/hep.510230526 · Cited by 124
Miros, M., Kerlin, P., Walker, N. I., Harper, J., Lynch, S. V., & Strong, R. W. (1991) · Gut · doi:10.1136/gut.32.11.1369 · Cited by 106
Risk of primary sclerosing cholangitis is associated with nonsmoking behavior
van Erpecum, K. J., Smits, S. R. J. G., van de Meeberg, P., Linn, F. H. H., Wolfhagen, F. H. J., Henegouwen, G. P. V. B., & Algra, A. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613056 · Cited by 105
Ricci, P., Therneau, T. M., Malinchoc, M., Benson, J. T., Petz, J., Klintmalm, G. B. G., Crippin, J. S., Wiesner, R. H., Steers, J. L., Rakela, J. L., et al. (1997) · Hepatology · doi:10.1002/hep.510250330 · Cited by 104
Lin, H., Kauffman, H. M., McBride, M., Davies, D. B., Rosendale, J. D., Smith, C. M., Edwards, E. B., Daily, O. P., Kirklin, J. K., Shield, C. F., et al. (1998) · JAMA · doi:10.1001/jama.280.13.1153 · Cited by 104
Knechtle, S. J., D’Alessandro, A. M., Harms, B. A., Pirsch, J. D., Belzer, F. O., & Kalayoğlu, M. (1995) · Surgery · doi:10.1016/s0039-6060(05)80026-1 · Cited by 98
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.
Abu-Elmagd, K. M., Malinchoc, M., Dickson, E. R., Fung, J. J., Murtaugh, P. A., Langworthy, A. L., Demetris, A. J., Krom, R. A. F., Thiel, D. H. V., & Starzl, T. E. (1993) · PubMed · Cited by 97
Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
Chijiiwa, K., Ichimiya, H., Kuroki, S., et al. (1993) · PubMed · Cited by 80
Rogers, S. (1994) · Hepatology · doi:10.1016/0270-9139(94)90038-8 · Cited by 71
Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation.
Stieber, A. C., Marino, I. R., Iwatsuki, S., & Starzl, T. E. (1989) · PubMed · Cited by 70
Surgical Aspects of Sclerosing Cholangitis
MARTIN, F. M., Rossi, R. L., Nugent, F. W., Scholz, F. J., Jenkins, R. L., LEWIS, W. D., Gagner, M., FOLEY, E., & Braasch, J. W. (1990) · Annals of Surgery · doi:10.1097/00000658-199010000-00017 · Cited by 54
Wiesner, R. H. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.6.575 · Cited by 52
Fisher, A., Theise, N. D., Min, A. D., Mor, E., Emre, S., Pearl, A. W., Schwartz, M., Miller, C. M., & Sheiner, P. A. (1995) · Liver Transplantation and Surgery · doi:10.1002/lt.500010204 · Cited by 44
Rogers, S. A., & Podolsky, D. K. (1994) · Hepatology · doi:10.1002/hep.1840190239 · Cited by 13
Cited by
Razumilava, N., & Gores, G. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61903-0 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., Krom, R. A. F., & Kim, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25879 · Cited by 864
Metadata
- Authors
- Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., & Hoen, H.
- Venue
- Hepatology
- Published
- 2000-01
- Volume
- 31
- Issue
- 1
- Pages
- 7-11
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2027658027
- Cited by
- 336
- References
- 28
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.